T cell receptor Vβ gene usage in Guillain-Barre syndrome

Journal of the Neurological Sciences

Volumn 145, Issue 2, 1997, Pages 169-176

  Khalili Shirazi, A ^a   Gregson, N A ^a   Hall, M A ^a   Hughes, R A C ^a   Lanchbury, J S ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

AIDP; GBS; T cell receptor; V gene

Indexed keywords

COMPLEMENTARY DNA; RNA;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CASE REPORT; CELL FRACTIONATION; CONTROLLED STUDY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE;

ADULT; AGED; CELL LINE; DNA, COMPLEMENTARY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYELIN PROTEINS; POLYMERASE CHAIN REACTION; POLYRADICULONEUROPATHY; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, INTERLEUKIN-2; RNA; T-LYMPHOCYTES;

EID: 0030900513     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(96)00257-2     Document Type: Article

References (36)

1. Asbury A.K., Arnason B.G., Adams R.D. The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine. 48:1969;173-215.
2. Asbury A.K., Cornblath D.R. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann. Neurol. 27(suppl):1990;s21-S24.
3. Birnbaum G., Van Ness B. Quantitation of T cell receptor Vβ chain expression as lymphocytes from blood, brain, and spinal fluid in patients with multiple sclerosis and other neurological diseases. Ann. Neurol. 32:1992;24-30.
4. Choi Y., Kotzin B.L., Herron L., Callahan J., Marrack P. Interaction of S. aureus toxin superantigens with human T cells. Proc. Natl. Acad. Sci. USA. 86:1989;8941-8945.
5. Choi Y., Lafferty J.A., Clements J.R., Todd J.K., Gelfand E.W., Kappler J., Marrack P., Kotzin B.L. Selective Expansion of T Cells Expressing Vβ 2 in Toxic Shock Syndrome. J. Exp. Med. 172:1990;981-984.
6. Clark L., Herber-Katz E., Rostami A Shared T-cell receptor gene usage in experimental allergic neuritis and encephalomyelitis. Ann. Neurol. 31:1992;587-592.
7. Gammon G., Sercarz E.E., Benichou G. The dominant self and the cryptic self: shaping the autoreactive T-cell repertoir. Immunol. Today. 12:1991;193-195.
8. Geursen A., Skinner M.A., Townsend L.A., Perko L.K., Farmiloe S.J., Peake J.S., Simpson I.J., Fraser J.D., Tan P.L.J. Population study of T cell receptor Vβ gene usage in peripheral blood lymphocytes: differences in ethnic groups. Clin. Exp. Immunol. 94:1993;201-207.
9. Gold R., Giegerich G., Hartung H.-P., Toyka K.V. T-cell receptor (TCR) usage in Lewis rat experimental autoimmune encephalomyelitis: TCR β-chain-variable-region Vβ8.2-positive T cells are not essential for induction and course of disease. Proc. Natl. Acad. Sci. USA. 92:1995;5850-5854.
10. Griffin J.W., Li C.Y., Ho T.W., Xue P., Macko C., Gao C.Y., Yang C., Tian M., Mishu B., Cornblath D.R., McKhann G.M., Asbury A.K. Guillain Barré Syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases. Brain. 118:1995;577-595.
11. Hall M.A., Lanchbury J.S. Healthy human T cell receptor β chain repertoire: quantitative analysis and evidence for Jβ related effects on CDR3. Human Immunol. 43:1995;207-218.
12. Hartung H.-P., Hughes R.A.C., Taylor W.A., Heininger K., Reiners K., Toyka K.V. T cell activation in Guillain-Barré syndrome and in MS: Elevated serum levels of soluble IL-2 receptors. Neurology. 40:1990;215-218.
13. Hartung H.P., Pollard J.D., Harvey G.K., Toyka K.V. Immunopathogenesis and traetment of the Guillain-Barré syndrome. Muscle Nerve. 18:1995;137-164.
14. Honavar M., Tharakan J.K.J., Hughes R.A.C., Leibowitz S., Winer J.B. A clinicopathological study of Guillain-Barré syndrome: nine cases and literature review. Brain. 114:1991;1245-1270.
15. Hughes, R.A.C. (1990) Guillain-Barré Syndrome. Heidelberg, Springer-Verlag.
16. Hughes R.A.C., Atkinson P., Coates P., Hall S., Leibowitz S. Sural nerve biopsies in Guillain-Barré syndrome: axonal degeneration and macrophage-mediated demyelination and absence of cytomegalovirus genome. Muscle Nerve. 15:1992;568-575.
17. Imrich H., Kugler C., Toues-Nagel N., Dories R., Hunig T. Prevention and treatment of Lewis rat EAE with monoclonal antibody to T cell receptor Vβ8.2 segment. Eur. J. Immunol. 25:1995;1960-1964.
18. 2. Brain Res. 184:1981;439-454.
19. Kelman B., Hansjuerg A., Lublin F.D. Characteristics of the T lymphocytes involved in experimental allergic encephalomyelitis. J. Neuroimmunol. 61:1995;107-116.
20. Khalili-Shirazi A., Hughes R.A.C., Brostoff S., Linington C., Gregson N. T cell response to myelin proteins in Guillain-Barré syndrome. J. Neurol. Sci. 111:1992;200-203.
21. 2 myelin proteins in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy. J. Neuroimmunol. 46:1993;245-252.
22. Lee S.J., Wucherpfennig K.W., Brod S.A., Benjamin D., Weiner H.L., Hafler D.A. Common T-cell receptor Vβ usage in oligoclonal T lymphocytes derived from cerebrospinal fluid and blood of patients with multiple sclerosis. Ann. Neurol. 29:1991;33-40.
23. Lehmann P.V., Forsthuber T., Miller A., Sercarz E.E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature. 358:1992;155-157.
24. 0 specific T cell lines. Eur. J. Immunol. 22:1992;1813-1817.
25. Loveridge J.A., Rosenberg W.M.C., Kirkwood T.B.L., Bell J.I. The genetic contribution to human T-cell receptor repertoire. Immunology. 74:1991;246-250.
26. Mac Donald H.R., Acha-Orbea H. Superantigen as suspect. Nature. 371:1994;283.
27. McKhann G.M., Cornblath D.R., Griffin J.W., Ho T.W., Li C.Y., Jiang Z., Wu H.S., Zhaori G., Liu Y., Jou P.L., Liu T.C., Gao C.Y., Mao J.Y., Blaser M.J., Mishu B., Asbury A.K. Acute motor axonal neuropathy: A frequent cause of acute flaccid paralysis in China. Ann. Neurol. 33:1993;333-342.
28. Oksenberg J.R., Panzara M.A., Begovich A.B., Mitchell D., Erlich H.A., Murray R.S., Shimonkevitz R., Sherritt M., Rothbard J., Bernard C.C., Steinman L. Selection for T-cell receptor Vβ-Dβ-Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature. 362:1993;68-70.
29. Richert J.R., Robinson E.D., Johnson A.H.et al. Heterogeneity of the T-cell receptor β gene rearrangements generated in myelin basic protein-specific T-cell clones isolated from a patient with multiple sclerosis. Ann. Neurol. 29:1991;299-306.
30. Robinson M.A. Usage of human T-cell receptor Vβ, Jβ, Cβ and Vα gene segments is not proportional to gene number. Human Immunol. 35:1992;60-67.
31. Rosenberg W.M.C., Moss P.A.H., Bell J.I. variation in human T cell receptor Vβ and Jβ repertoire: analysis using anchor polymerase chain reaction. Eur. J. Immunology. 22:1992;541-549.
32. Taylor W.A., Hughes R.A.C. T lymphocyte activation antigenes in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy. J. Neuroimmunol. 24:1989;33-39.
33. 2specific lymphocyte transformation in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropthy. J. Neurol. Sci. 104:1991;52-55.
34. β repertoire and cytokine gene expression in active multiple sclerosis lesions. J. Exp. Med. 175:1992;993-1002.
35. Wucherpfennig K.W., Strominger J.L. Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein. Cell. 80:1995;695-705.
36. Zhang X.-M., Esch T.R., Clark L., Gregorian S., Rostami A., Otvos L., Herber-Katz E. Neuritogenic Lewis rat T cells use TCRb chains that include a new TCRb-V8 family member. Immunogenetics. 40:1994;266-270.